Molecular pathologic diagnosis of epidermal growth factor receptor
Epidermal growth factor receptor (EGFR) was one of the first oncogenes identified in
glioblastoma (GBM) and remains one of the most attractive therapeutic targets. Genomic …
glioblastoma (GBM) and remains one of the most attractive therapeutic targets. Genomic …
FISHing tips: what every clinician should know about 1p19q analysis in gliomas using fluorescence in situ hybridisation
MB Pinkham, N Telford, GA Whitfield, RJ Colaco… - Clinical Oncology, 2015 - Elsevier
Abstract 1p19q co-deletion is a chromosomal alteration associated with primary brain
tumours of oligodendroglial histology. It is an established predictive and prognostic …
tumours of oligodendroglial histology. It is an established predictive and prognostic …
Microfoci of malignant progression in diffuse low-grade gliomas: towards the creation of an intermediate grade in glioma classification?
Z Pedeutour-Braccini, F Burel-Vandenbos, C Gozé… - Virchows Archiv, 2015 - Springer
Low-grade gliomas (GII) inescapably progress to high-grade gliomas (GIII). The duration of
this transition is highly variable between patients and reliable predictive markers do not …
this transition is highly variable between patients and reliable predictive markers do not …
Molecular analysis of pediatric oligodendrogliomas highlights genetic differences with adult counterparts and other pediatric gliomas
Oligodendroglioma represents a distinctive neoplasm in adults but similar neoplasms occur
rarely in children. We studied 20 cases of pediatric oligodendroglioma by SNP array …
rarely in children. We studied 20 cases of pediatric oligodendroglioma by SNP array …
Diagnostic test accuracy and cost‐effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma
Background Complete deletion of both the short arm of chromosome 1 (1p) and the long arm
of chromosome 19 (19q), known as 1p/19q codeletion, is a mutation that can occur in …
of chromosome 19 (19q), known as 1p/19q codeletion, is a mutation that can occur in …
DNA fragmentation simulation method (FSM) and fragment size matching improve aCGH performance of FFPE tissues
Whole-genome copy number analysis platforms, such as array comparative genomic
hybridization (aCGH) and single nucleotide polymorphism (SNP) arrays, are transformative …
hybridization (aCGH) and single nucleotide polymorphism (SNP) arrays, are transformative …
[HTML][HTML] Genomic changes in gliomas detected using single nucleotide polymorphism array in formalin-fixed, paraffin-embedded tissue: superior results compared …
S Harada, LB Henderson, JR Eshleman… - The Journal of Molecular …, 2011 - Elsevier
Deletion or loss of heterozygosity (LOH) in chromosomes 1p and 19q in oligodendrogliomas
(ODGs) have diagnostic, prognostic, and therapeutic implications. Current clinical assays …
(ODGs) have diagnostic, prognostic, and therapeutic implications. Current clinical assays …
Something old and something new about molecular diagnostics in gliomas
C Horbinski - Surgical pathology clinics, 2012 - Elsevier
Progress in understanding the molecular biology of neoplasms has been driven by
remarkable improvements in molecular biology techniques, creating a rapidly moving field in …
remarkable improvements in molecular biology techniques, creating a rapidly moving field in …
Comparable genomic copy number aberrations differ across astrocytoma malignancy grades
N Pećina-Šlaus, A Kafka, K Gotovac Jerčić… - International Journal of …, 2019 - mdpi.com
A collection of intracranial astrocytomas of different malignancy grades was analyzed for
copy number aberrations (CNA) in order to identify regions that are driving cancer …
copy number aberrations (CNA) in order to identify regions that are driving cancer …
Chromosomal aberrations in bladder cancer: fresh versus formalin fixed paraffin embedded tissue and targeted FISH versus wide microarray-based CGH analysis
E Panzeri, D Conconi, L Antolini, S Redaelli… - PLoS …, 2011 - journals.plos.org
Bladder carcinogenesis is believed to follow two alternative pathways driven by the loss of
chromosome 9 and the gain of chromosome 7, albeit other nonrandom copy number …
chromosome 9 and the gain of chromosome 7, albeit other nonrandom copy number …